{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:54:19Z","timestamp":1789268059051,"version":"build-2803163510"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AMB Expr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Amikacin (AMK), a potent aminoglycoside antibiotic, is clinically valuable for severe Gram-negative infections but is limited by its nephrotoxic and hepatotoxic effects, primarily mediated through oxidative stress and inflammation. This study investigated the protective role of pentoxifylline (PTX), a methylxanthine derivative with antioxidant and anti-inflammatory properties, against AMK-induced organ damage in male BALB\/c mice. Thirty mice were divided into six groups: control, AMK (100\u00a0mg\/kg\/day), PTX monotherapy (50 or 100\u00a0mg\/kg\/day), and AMK combined with PTX (50 or 100\u00a0mg\/kg\/day). After 28 days, biochemical, oxidative stress, inflammatory, and histopathological analyses were conducted. AMK administration significantly elevated renal (BUN and creatinine) and hepatic (ALT, AST and ALP) markers, increased oxidative stress (MDA), and upregulated inflammatory cytokines (IL-17), alongside histopathological damage in kidney and liver tissues. Co-treatment with PTX, particularly at 100\u00a0mg\/kg, normalized these parameters, restored antioxidant defenses, reduced inflammation, and preserved tissue architecture. PTX demonstrated dose-dependent efficacy, with the higher dose offering complete protection against AMK-induced toxicity. These findings highlighted PTX\u2019s potential as an adjunctive therapy to mitigate AMK-associated nephrotoxicity and hepatotoxicity, suggesting its clinical utility in optimizing aminoglycoside safety without compromising efficacy.<\/jats:p>","DOI":"10.1186\/s13568-025-01949-8","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:13:31Z","timestamp":1761135211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Amikacin toxicity revisited: pentoxifylline offers protection in high-risk treatment scenarios"],"prefix":"10.1186","volume":"15","author":[{"given":"Nada","family":"Moustafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona B. Abd","family":"El-latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0706-347X","authenticated-orcid":false,"given":"Alyaa","family":"Farid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"1949_CR1","first-page":"596","volume":"57","author":"OM Abdel Salam","year":"2005","unstructured":"Abdel Salam OM, Baiuomy AR, El-Shenawy SM, Hassan NS (2005) Effect of pentoxifylline on hepatic injury caused in the rat by the administration of carbon tetrachloride or acetaminophen. Pharmacol Rep 57:596\u2013603","journal-title":"Pharmacol Rep"},{"key":"1949_CR3","doi-asserted-by":"publisher","first-page":"116387","DOI":"10.1016\/j.taap.2023.116387","volume":"461","author":"L Al-Kharashi","year":"2023","unstructured":"Al-Kharashi L, Attia H, Alsaffi A, Almasri T, Arafa M, Hasan I, Alajami H, Ali R, Badr A (2023) Pentoxifylline and thiamine ameliorate rhabdomyolysis-induced acute kidney injury in rats via suppressing TLR4\/NF-\u03baB and NLRP-3\/caspase-1\/gasdermin mediated-pyroptosis. Toxicol Appl Pharmacol 461:116387","journal-title":"Toxicol Appl Pharmacol"},{"key":"1949_CR2","doi-asserted-by":"publisher","first-page":"e70115","DOI":"10.1002\/prp2.70115","volume":"13","author":"FA Alherz","year":"2025","unstructured":"Alherz FA, Abdallah MS, Mosalam EM, Bahaa MM, Elmasry TA, El-Gammal MA, Negm WA, Elberri A, Elshorbagi N, Abo Mansour HE, Hamouda AO, Salahuddin MM, Yasser M, Eldesoqui M, Alrubia S, Alsegiani AS, El-Khateeb E, ElMahdy MK, Wahsh E (2025) Colo-protective effects of pentoxifylline alone or in combination with mesalamine in colitis through sphingosine kinase 1\/sphingosine 1 phosphate, and Zonula occuldin 1 pathways: new molecular approach. Pharmacol Res Perspect 13:e70115","journal-title":"Pharmacol Res Perspect"},{"key":"1949_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s15010-009-9193-9","volume":"38","author":"J Ambrosioni","year":"2010","unstructured":"Ambrosioni J, Lew D, Garbino J (2010) Nocardiosis: updated clinical review and experience at a tertiary center. Infection 38:89\u201397","journal-title":"Infection"},{"key":"1949_CR5","first-page":"5","volume":"10","author":"M Amirteimoury","year":"2023","unstructured":"Amirteimoury M, Fatemi I (2023) Myrtenol protects against acute kidney injury induced by cisplatin in mice. Res J Pharmacogn 10:5\u201313","journal-title":"Res J Pharmacogn"},{"key":"1949_CR6","unstructured":"Aronson JK (2009) Meyler\u2019s side effects of antimicrobial drugs. Elsevier"},{"key":"1949_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3109\/0886022X.2014.967645","volume":"37","author":"H A\u015f\u00e7\u0131","year":"2015","unstructured":"A\u015f\u00e7\u0131 H, Sayg\u0131n M, \u00c7ankara FN, Bayram D, Ye\u015filot S, Candan \u0130A, \u0130lhan \u0130 (2015) The impact of alpha-lipoic acid on amikacin-induced nephrotoxicity. Ren Fail 37:117\u2013121","journal-title":"Ren Fail"},{"key":"1949_CR8","first-page":"1003","volume":"15","author":"I Asvadi","year":"2011","unstructured":"Asvadi I, Hajipour B, Asvadi A, Asl NA, Roshangar L, Khodadadi A (2011) Protective effect of pentoxyfilline in renal toxicity after methotrexate administration. Eur Rev Med Pharmacol Sci 15:1003\u20131009","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1949_CR9","doi-asserted-by":"publisher","first-page":"574","DOI":"10.33263\/BRIAC136.574","volume":"13","author":"S Azirak","year":"2023","unstructured":"Azirak S, \u00d6zg\u00f6\u00e7men M (2023) The protective effects of misoprostol against amikacin-induced liver injury. Biointerface Res Appl Chem 13:574","journal-title":"Biointerface Res Appl Chem"},{"key":"1949_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.30954\/2277-940X.06.2018.11","volume":"8","author":"AS Batoo","year":"2018","unstructured":"Batoo AS, Hussain K, Singh R, Sultana M, Sharma N, Nabi B, Najar AA, Chaudhary S (2018) Biochemical and oxidative alterations induced by acute Amikacin toxicity in albino Wistar rats. J Anim Res 8:407\u2013410","journal-title":"J Anim Res"},{"key":"1949_CR11","first-page":"563","volume":"22","author":"G Bazmandegan","year":"2019","unstructured":"Bazmandegan G, Amirteimoury M, Kaeidi A, Shamsizadeh A, Khademalhosseini M, Nematollahi MH, Hassanipour M, Fatemi I (2019) Sumatriptan ameliorates renal injury induced by cisplatin in mice. Iran J Basic Med Sci 22:563\u2013567","journal-title":"Iran J Basic Med Sci"},{"key":"1949_CR12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00210-020-01990-3","volume":"394","author":"G Bazmandegan","year":"2021","unstructured":"Bazmandegan G, Fatemi I, Kaeidi A, Khademalhosseini M, Fathinejad A, Amirteimoury M (2021) Calcium dobesilate prevents cisplatin-induced nephrotoxicity by modulating oxidative and histopathological changes in mice. Naunyn Schmiedebergs Arch Pharmacol 394:515\u2013521","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1949_CR13","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.autrev.2018.06.008","volume":"17","author":"A Beringer","year":"2018","unstructured":"Beringer A, Miossec P (2018) IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases. Autoimmun Rev 17:1176\u20131185","journal-title":"Autoimmun Rev"},{"key":"1949_CR14","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1056\/NEJMra1208937","volume":"369","author":"W Bernal","year":"2013","unstructured":"Bernal W, Wendon J (2013) Acute liver failure. N Engl J Med 369:2525\u20132534","journal-title":"N Engl J Med"},{"key":"1949_CR15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jcmgh.2017.12.012","volume":"5","author":"KA Bockerstett","year":"2018","unstructured":"Bockerstett KA, Osaki LH, Petersen CP, Cai CW, Wong CF, Nguyen TM, Ford EL, Hoft DF, Mills JC, Goldenring JR, DiPaolo RJ (2018) Interleukin-17A promotes parietal cell atrophy by inducing apoptosis. Cell Mol Gastroenterol Hepatol 5:678\u2013690","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1949_CR16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1590\/S0102-86502013001100004","volume":"28","author":"JL Brasileiro","year":"2013","unstructured":"Brasileiro JL, Inoye CM, Aydos RD, Silva IS, Falc\u00e3o GR, Marks G, Pereira DM (2013) Ischemia and reperfusion of rat small intestine using pentoxyfilline and prostaglandin E1. Acta Cir Bras 28:767\u2013773","journal-title":"Acta Cir Bras"},{"key":"1949_CR17","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S1473-3099(10)70139-0","volume":"10","author":"JA Caminero","year":"2010","unstructured":"Caminero JA, Sotgiu G, Zumla A, Migliori GB (2010) Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis 10:621\u2013629","journal-title":"Lancet Infect Dis"},{"key":"1949_CR18","first-page":"152","volume":"25","author":"HK Cha","year":"2008","unstructured":"Cha HK, Gwak HS, Park YH, Ryu SG, Kim JY, Song YC (2008) The effects of liver disease on Amikacin-induced nephrotoxicity. J Korean Soc Health-Syst Pharm 25:152\u2013158","journal-title":"J Korean Soc Health-Syst Pharm"},{"key":"1949_CR19","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.ajpath.2014.01.023","volume":"184","author":"AJ Chan","year":"2014","unstructured":"Chan AJ, Alikhan MA, Odobasic D, Gan PY, Khouri MB, Steinmetz OM, Mansell AS, Kitching AR, Holdsworth SR, Summers SA (2014) Innate IL-17A-producing leukocytes promote acute kidney injury via inflammasome and Toll-like receptor activation. Am J Pathol 184:1411\u20131418","journal-title":"Am J Pathol"},{"key":"1949_CR20","doi-asserted-by":"publisher","first-page":"e01028","DOI":"10.1128\/AAC.00859-20","volume":"64","author":"K Chan","year":"2020","unstructured":"Chan K, Ledesma KR, Wang W, Tam VH (2020) Characterization of Amikacin drug exposure and nephrotoxicity in an animal model. Antimicrob Agents Chemother 64:e01028\u2013e01020","journal-title":"Antimicrob Agents Chemother"},{"key":"1949_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1039\/C5MD00453E","volume":"7","author":"NT Chandrika","year":"2016","unstructured":"Chandrika NT, Garneau-Tsodikova S (2016) A review of patents (2011\u20132015) towards combating resistance to and toxicity of aminoglycosides. MedChemComm 7:50\u201368","journal-title":"MedChemComm"},{"key":"1949_CR22","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.trstmh.2008.09.008","volume":"103","author":"RN Davidson","year":"2009","unstructured":"Davidson RN, den Boer M, Ritmeijer K (2009) Paromomycin. Trans R Soc Trop Med Hyg 103:653\u2013660","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1949_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/ja.2006.73","volume":"59","author":"J Davies","year":"2006","unstructured":"Davies J (2006) Aminoglycosides: ancient and modern. J Antibiot 59:529\u2013532","journal-title":"J Antibiot"},{"key":"1949_CR24","doi-asserted-by":"publisher","first-page":"e06868","DOI":"10.1016\/j.heliyon.2021.e06868","volume":"9","author":"AO Dhulqarnain","year":"2021","unstructured":"Dhulqarnain AO, Takzaree N, Hassanzadeh G, Tooli H, Malekzadeh M, Khanmohammadi N, Yaghobinejad M, Solhjoo S, Rastegar T (2021) Pentoxifylline improves the survival of spermatogenic cells via oxidative stress suppression and upregulation of PI3K\/AKT pathway in mouse model of testicular torsion-detorsion. Heliyon 9:e06868","journal-title":"Heliyon"},{"key":"1949_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3748\/wjg.v20.i2.569","volume":"20","author":"J Du","year":"2014","unstructured":"Du J, Ma YY, Yu CH, Li YM (2014) Effects of Pentoxifylline on nonalcoholic fatty liver disease: a meta-analysis. World J Gastroenterol 20:569\u2013577","journal-title":"World J Gastroenterol"},{"key":"1949_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/0886022X.2017.1326384","volume":"39","author":"V Ehsani","year":"2017","unstructured":"Ehsani V, Amirteimoury M, Taghipour Z, Shamsizadeh A, Bazmandegan G, Rahnama A, Khajehasani F, Fatemi I (2017) Protective effect of hydroalcoholic extract of pistacia vera against gentamicin-induced nephrotoxicity in rats. Ren Fail 39:519\u2013525","journal-title":"Ren Fail"},{"key":"1949_CR27","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1139\/cjpp-2016-0115","volume":"94","author":"SM Elshazly","year":"2016","unstructured":"Elshazly SM, Mahmoud AAA, Barakat W (2016) Pentoxifylline abrogates cardiotoxicity induced by the administration of a single high dose or multiple low doses of doxorubicin in rats. Can J Physiol Pharmacol 94:1170\u20131177","journal-title":"Can J Physiol Pharmacol"},{"key":"1949_CR28","first-page":"375","volume":"51","author":"P Entzian","year":"1997","unstructured":"Entzian P, Gerlach C, Gerdes J, Schlaak M, Zabel P (1997) Pentoxifyllin inhibiert die experimentelle bleomycininduzierte fibrosierende alveolitis. Pneumologie 51:375\u2013380","journal-title":"Pneumologie"},{"key":"1949_CR29","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1021\/acs.joc.5b00248","volume":"80","author":"MY Fosso","year":"2015","unstructured":"Fosso MY, AlFindee MN, Zhang Q, Nziko VP, Kawasaki Y, Shrestha SK, Bearss J, Gregory R, Takemoto JY, Chang CW (2015) Structure-activity relationships for antibacterial to antifungal conversion of Kanamycin to amphiphilic analogues. J Org Chem 80:4398\u20134411","journal-title":"J Org Chem"},{"key":"1949_CR30","doi-asserted-by":"publisher","first-page":"e17224","DOI":"10.1371\/journal.pone.0017224","volume":"6","author":"GF Gad","year":"2011","unstructured":"Gad GF, Mohamed HA, Ashour HM (2011) Aminoglycoside resistance rates, phenotypes, and mechanisms of Gram-negative bacteria from infected patients in upper Egypt. PLoS ONE 6:e17224","journal-title":"PLoS ONE"},{"key":"1949_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12950-015-0080-5","volume":"12","author":"FA Garcia","year":"2015","unstructured":"Garcia FA, Rebou\u00e7as JF, Balbino TQ, da Silva TG, de Carvalho-J\u00fanior CH, Cerqueira GS, Brito GA, Viana GS (2015) Pentoxifylline reduces the inflammatory process in diabetic rats: relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthase. J Inflamm (Lond) 12:33","journal-title":"J Inflamm (Lond)"},{"key":"1949_CR32","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1128\/AAC.35.7.1284","volume":"35","author":"DN Gerding","year":"1991","unstructured":"Gerding DN, Larson TA, Hughes RA, Weiler M, Shanholtzer C, Peterson LR (1991) Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother 35:1284\u20131290","journal-title":"Antimicrob Agents Chemother"},{"key":"1949_CR33","doi-asserted-by":"publisher","first-page":"E21","DOI":"10.1503\/cmaj.140848","volume":"187","author":"M Gillies","year":"2015","unstructured":"Gillies M, Ranakusuma A, Hoffmann T, Thorning S, McGuire T, Glasziou P, Del Mar C (2015) Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication. CMAJ 187:E21\u2013E31","journal-title":"CMAJ"},{"key":"1949_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.31185\/wjps.268","volume":"0","author":"AA Habeeb","year":"2023","unstructured":"Habeeb AA (2023) Investigation of the physiological effects of Amikacin and the protective role of L-carnitine and vitamin C in adult male rats. Wasit J Pure Sci 0:175\u2013184","journal-title":"Wasit J Pure Sci"},{"key":"1949_CR35","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/cbic.200900779","volume":"11","author":"JL Houghton","year":"2010","unstructured":"Houghton JL, Green KD, Chen W, Garneau-Tsodikova S (2010) The future of aminoglycosides: The end or renaissance? ChemBioChem 11:880\u2013902","journal-title":"ChemBioChem"},{"key":"1949_CR36","doi-asserted-by":"publisher","first-page":"118196","DOI":"10.1016\/j.lfs.2020.118196","volume":"258","author":"MD Inacio","year":"2020","unstructured":"Inacio MD, Costa MC, Lima TFO, Figueiredo ID, Motta BP, Spolidorio LC, Assis RP, Brunetti IL, Baviera AM (2020) Pentoxifylline mitigates renal glycoxidative stress in obese mice by inhibiting AGE\/RAGE signaling and increasing glyoxalase levels. Life Sci 258:118196","journal-title":"Life Sci"},{"key":"1949_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.31351\/vol32iss1pp219-226","volume":"32","author":"AA Jaccolo","year":"2023","unstructured":"Jaccolo AA, Dari FF, AL-Moziel MS (2023) The impact of citrus Bergamot extract on hemato-biochemical, inflammatory, and oxidative stress parameters induced by acute Amikacin toxicity in male albino rats. Iraqi J Pharm Sci 32:219\u2013226","journal-title":"Iraqi J Pharm Sci"},{"key":"1949_CR38","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1182\/blood-2005-03-1307","volume":"106","author":"PD James","year":"2005","unstructured":"James PD, Raut S, Rivard GE, Poon MC, Warner M, McKenna S, Leggo J, Lillicrap D (2005) Aminoglycoside suppression of nonsense mutations in severe hemophilia. Blood 106:3043\u20133048","journal-title":"Blood"},{"key":"1949_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1126\/science.100.2588.103.b","volume":"100","author":"D Jones","year":"1944","unstructured":"Jones D, Metzger HJ, Schatz A, Waksman SA (1944) Control of gram-negative bacteria in experimental animals by streptomycin. Science 100:103\u2013105","journal-title":"Science"},{"key":"1949_CR40","first-page":"57","volume":"8","author":"PL Kadam","year":"2013","unstructured":"Kadam PL, Kengar SB, Patil RN, Chavan MP, Nanware SS, Patil SS (2013) Toxic effect of Amikacin sulphate on liver and kidney on white (Albino) rat. Asian J Bio Sci 8:57\u201359","journal-title":"Asian J Bio Sci"},{"key":"1949_CR41","unstructured":"Kalakonda A, Jenkins BA, John S (2017) Physiology, bilirubin. In: StatPearls. StatPearls Publishing"},{"key":"1949_CR42","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1039\/c1ib00034a","volume":"3","author":"T Karasawa","year":"2011","unstructured":"Karasawa T, Steyger PS (2011) Intracellular mechanisms of aminoglycoside-induced cytotoxicity. Integr Biol 3:879\u2013886","journal-title":"Integr Biol"},{"key":"1949_CR43","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3109\/10409238.2012.694846","volume":"47","author":"KM Keeling","year":"2012","unstructured":"Keeling KM, Wang D, Conard SE, Bedwell DM (2012) Suppression of premature termination codons as a therapeutic approach. Crit Rev Biochem Mol Biol 47:444\u2013463","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"1949_CR44","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1128\/AAC.44.12.3249-3256.2000","volume":"44","author":"LP Kotra","year":"2000","unstructured":"Kotra LP, Haddad J, Mobashery S (2000) Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance. Antimicrob Agents Chemother 44:3249\u20133256","journal-title":"Antimicrob Agents Chemother"},{"key":"1949_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/0976-0105.183260","volume":"7","author":"T Kova\u010devi\u0107","year":"2016","unstructured":"Kova\u010devi\u0107 T, Avram S, Milakovi\u0107 D, \u0160piri\u0107 N, Kova\u010devi\u0107 P (2016) Therapeutic monitoring of Amikacin and gentamicin in critically and noncritically ill patients. J Basic Clin Pharm 7:65\u201369","journal-title":"J Basic Clin Pharm"},{"key":"1949_CR46","unstructured":"Lacy CF, Armstrong LL, Lipsy RJ (1993) Drug information handbook 1993. Lexi-comp"},{"key":"1949_CR47","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1016\/0006-2952(82)90303-3","volume":"31","author":"G Laurent","year":"1982","unstructured":"Laurent G, Carlier MB, Rollman B, Van Hoof F, Tulkens P (1982) Mechanism of aminoglycoside-induced lysosomal phospholipidosis. Biochem Pharmacol 31:3861\u20133870","journal-title":"Biochem Pharmacol"},{"key":"1949_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/0002-9343(86)90486-9","volume":"80","author":"SA Lerner","year":"1986","unstructured":"Lerner SA, Schmitt BA, Seligsohn R, Matz GJ (1986) Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with Amikacin or gentamicin. Am J Med 80:98\u2013104","journal-title":"Am J Med"},{"key":"1949_CR49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/15476910903501748","volume":"7","author":"J Li","year":"2010","unstructured":"Li J, Zhu X, Liu F, Cai P, Sanders C, Lee WM, Uetrecht J (2010a) Cytokine and autoantibody patterns in acute liver failure. J Immunotoxicol 7:157\u2013164","journal-title":"J Immunotoxicol"},{"key":"1949_CR50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1172\/JCI38702","volume":"120","author":"L Li","year":"2010","unstructured":"Li L, Huang L, Vergis AL, Ye H, Bajwa A, Narayan V, Strieter RM, Rosin DL, Okusa MD (2010b) IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 120:331\u2013342","journal-title":"J Clin Invest"},{"key":"1949_CR51","unstructured":"MacDougall C, Chambers H (2011) Aminoglycosides. In: Brunton L, Chamber B, Knollman B (eds) The pharmacological basis of therapeutics. McGraw Hill, pp 1507\u20131517"},{"key":"1949_CR52","doi-asserted-by":"publisher","first-page":"109988","DOI":"10.1016\/j.mehy.2020.109988","volume":"144","author":"V Maldonado","year":"2020","unstructured":"Maldonado V, Loza-Mej\u00eda MA, Ch\u00e1vez-Alderete J (2020) Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19. Med Hypotheses 144:109988","journal-title":"Med Hypotheses"},{"key":"1949_CR53","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40262-016-0428-x","volume":"56","author":"A Marsot","year":"2017","unstructured":"Marsot A, Guilhaumou R, Riff C, Blin O (2017) Amikacin in critically ill patients: a review of population pharmacokinetic studies. Clin Pharmacokinet 56:127\u2013138","journal-title":"Clin Pharmacokinet"},{"key":"1949_CR54","first-page":"41","volume":"32","author":"G Martines","year":"1988","unstructured":"Martines G, Butturini L, Menozzi I et al (1988) Amikacin-induced liver toxicity: correlations between biochemical indexes and ultrastructural features in an experimental model. Rev Med Univ Navarra 32:41\u201345","journal-title":"Rev Med Univ Navarra"},{"key":"1949_CR55","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.3390\/ijms21134690","volume":"21","author":"L Martinez Valenzuela","year":"2020","unstructured":"Martinez Valenzuela L, Draibe J, Fulladosa X, Torras J (2020) New biomarkers in acute tubulointerstitial nephritis: a novel approach to a classic condition. Int J Mol Sci 21:4690","journal-title":"Int J Mol Sci"},{"key":"1949_CR56","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1053\/j.ajkd.2008.01.025","volume":"52","author":"BB McCormick","year":"2008","unstructured":"McCormick BB, Sydor A, Akbari A, Fergusson D, Doucette S, Knoll G (2008) The effect of Pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis. Am J Kidney Dis 52:454\u2013463","journal-title":"Am J Kidney Dis"},{"key":"1949_CR57","first-page":"1021","volume":"34","author":"S Mehboob","year":"2021","unstructured":"Mehboob S, Saleem DM, Mehboob M, Jahan N, Perveen S, Rafi SM, Anser H, Owais F (2021) Hepatotoxicity induced by chronic suppurative otitis media in rats and effects of Ceftazidime and Amikacin on it. Pak J Pharm Sci 34:1021\u20131028","journal-title":"Pak J Pharm Sci"},{"key":"1949_CR58","first-page":"1","volume":"71","author":"FR Mohammed","year":"2024","unstructured":"Mohammed FR, Hummadi YMKAM, Al-Ezzi MI (2024) Pentoxifylline ameliorates carbamazepine-induced hepatotoxicity via down expression of CYP3A4 and NF-kB gene expression in the rat: in vivo study. Pharmacia 71:1\u201311","journal-title":"Pharmacia"},{"key":"1949_CR59","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases (2019) Aminoglycosides. In: LiverTox: clinical and research information on drug-induced liver injury. Bethesda MD"},{"key":"1949_CR60","first-page":"4407","volume":"5","author":"G Pacifici","year":"2017","unstructured":"Pacifici G, Marchini G (2017) Clinical pharmacokinetics of Amikacin in neonates. Int J Pediatr 5:4407\u20134428","journal-title":"Int J Pediatr"},{"key":"1949_CR61","first-page":"1","volume":"5","author":"GM Pacifici","year":"2020","unstructured":"Pacifici GM, Marchini G (2020) Clinical Pharmacology of Amikacin in infants and children. Clin Med Insights 5:1\u201314","journal-title":"Clin Med Insights"},{"key":"1949_CR62","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1471-4159.2010.07136.x","volume":"116","author":"MK Paintlia","year":"2011","unstructured":"Paintlia MK, Paintlia AS, Singh AK, Singh I (2011) Synergistic activity of interleukin-17 and tumor necrosis factor-\u03b1 enhances oxidative stress-mediated oligodendrocyte apoptosis. J Neurochem 116:508\u2013521","journal-title":"J Neurochem"},{"key":"1949_CR63","first-page":"CD008234","volume":"8","author":"B Pullens","year":"2011","unstructured":"Pullens B, van Benthem PP (2011) Intratympanic gentamicin for meniere\u2019s disease or syndrome. Cochrane Database Syst Rev 8:CD008234","journal-title":"Cochrane Database Syst Rev"},{"key":"1949_CR64","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/0885066610377968","volume":"25","author":"EA Radigan","year":"2010","unstructured":"Radigan EA, Gilchrist NA, Miller MA (2010) Management of aminoglycosides in the intensive care unit. J Intensive Care Med 25:327\u2013342","journal-title":"J Intensive Care Med"},{"key":"1949_CR65","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.3390\/molecules22122267","volume":"22","author":"MS Ramirez","year":"2017","unstructured":"Ramirez MS, Tolmasky ME (2017) Amikacin: uses, resistance, and prospects for inhibition. Molecules 22:2267","journal-title":"Molecules"},{"key":"1949_CR66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00007691-198503000-00003","volume":"7","author":"AM Ristuccia","year":"1985","unstructured":"Ristuccia AM, Cunha BA (1985) An overview of Amikacin. Ther Drug Monit 7:12\u201325","journal-title":"Ther Drug Monit"},{"issue":"Suppl 1","key":"1949_CR67","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1590\/1806-9282.66.s1.82","volume":"66","author":"GTM Sales","year":"2020","unstructured":"Sales GTM, Foresto RD (2020) Drug-induced nephrotoxicity. Rev Assoc Med Bras 66(Suppl 1):82\u201390","journal-title":"Rev Assoc Med Bras"},{"key":"1949_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/emboj\/19.1.1","volume":"19","author":"R Schroeder","year":"2000","unstructured":"Schroeder R, Waldsich C, Wank H (2000) Modulation of RNA function by aminoglycoside antibiotics. EMBO J 19:1\u20139","journal-title":"EMBO J"},{"key":"1949_CR69","doi-asserted-by":"crossref","unstructured":"Serio AW, Magalh\u00e3es ML, Blanchard JS, Connolly LE (2017) Aminoglycosides: mechanisms of action and resistance. In: Mayers DL et al (eds) Antimicrobial drug resistance. Springer, pp 213\u2013229","DOI":"10.1007\/978-3-319-46718-4_14"},{"key":"1949_CR70","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1128\/mr.57.1.138-163.1993","volume":"57","author":"KJ Shaw","year":"1993","unstructured":"Shaw KJ, Rather PN, Hare RS, Miller GH (1993) Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev 57:138\u2013163","journal-title":"Microbiol Rev"},{"key":"1949_CR71","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00228-009-0637-4","volume":"65","author":"CM Sherwin","year":"2009","unstructured":"Sherwin CM, Svahn S, Van der Linden A, Broadbent RS, Medlicott NJ, Reith DM (2009) Individualised dosing of Amikacin in neonates: a pharmacokinetic\/pharmacodynamic analysis. Eur J Clin Pharmacol 65:705\u2013713","journal-title":"Eur J Clin Pharmacol"},{"key":"1949_CR72","first-page":"486","volume":"50","author":"A Siddiqi","year":"2009","unstructured":"Siddiqi A, Khan DA, Khan FA, Razzaq A (2009) Therapeutic drug monitoring of Amikacin in preterm and term infants. Singap Med J 50:486\u2013489","journal-title":"Singap Med J"},{"key":"1949_CR73","unstructured":"Sizar O, Rahman S, Sundareshan V (2023) Amikacin. In: StatPearls. StatPearls Publishing"},{"key":"1949_CR74","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/archinte.1978.03630290029013","volume":"138","author":"AR Sklaver","year":"1978","unstructured":"Sklaver AR, Greenman RL, Hoffman TA (1978) Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli. Arch Intern Med 138:713\u2013716","journal-title":"Arch Intern Med"},{"key":"1949_CR75","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1128\/CMR.05041-11","volume":"25","author":"PD Tamma","year":"2012","unstructured":"Tamma PD, Cosgrove SE, Maragakis LL (2012) Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev 25:450\u2013470","journal-title":"Clin Microbiol Rev"},{"key":"1949_CR76","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S1665-2681(19)31751-X","volume":"8","author":"A Taye","year":"2009","unstructured":"Taye A, El-Moselhy MA, Hassan MK, Ibrahim HM, Mohammed AF (2009) Hepatoprotective effect of Pentoxifylline against D-galactosamine-induced hepatotoxicity in rats. Ann Hepatol 8:364\u2013370","journal-title":"Ann Hepatol"},{"key":"1949_CR77","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1128\/AAC.00277-11","volume":"55","author":"C Tayman","year":"2011","unstructured":"Tayman C, El-Attug MN, Adams E, Van Schepdael A, Debeer A, Allegaert K, Smits A (2011) Quantification of Amikacin in bronchial epithelial lining fluid in neonates. Antimicrob Agents Chemother 55:3990\u20133993","journal-title":"Antimicrob Agents Chemother"},{"key":"1949_CR78","doi-asserted-by":"crossref","unstructured":"Tolmasky ME (2007) Aminoglycoside-modifying enzymes: Characteristics, localization, and dissemination. In: Bonomo RA, Tolmasky ME (eds) Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, pp 35\u201352","DOI":"10.1128\/9781555815615.ch4"},{"key":"1949_CR79","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0891-5520(03)00057-6","volume":"17","author":"JD Turnidge","year":"2003","unstructured":"Turnidge JD (2003) Pharmacodynamics and dosing of aminoglycosides. Infect Dis Clin North Am 17:503\u2013528","journal-title":"Infect Dis Clin North Am"},{"key":"1949_CR80","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1749-6632.1958.tb54688.x","volume":"76","author":"H Umezawa","year":"1958","unstructured":"Umezawa H (1958) Kanamycin: its discovery. Ann N Y Acad Sci 76:20\u201326","journal-title":"Ann N Y Acad Sci"},{"key":"1949_CR81","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1128\/CMR.16.3.430-450.2003","volume":"16","author":"SB Vakulenko","year":"2003","unstructured":"Vakulenko SB, Mobashery S (2003) Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev 16:430\u2013450","journal-title":"Clin Microbiol Rev"},{"key":"1949_CR82","doi-asserted-by":"crossref","unstructured":"Veyssier P, Bryskier A (2005) Aminocyclitol aminoglycosides. In: Bryskier A (ed) Antimicrobial agents. ASM, pp 453\u2013469","DOI":"10.1128\/9781555815929.ch16"},{"key":"1949_CR83","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1126\/science.109.2830.305","volume":"109","author":"SA Waksman","year":"1949","unstructured":"Waksman SA, Lechevalier HA (1949) Neomycin, a new antibiotic active against streptomycin-resistant bacteria, including tuberculosis organisms. Science 109:305\u2013307","journal-title":"Science"},{"key":"1949_CR84","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/antiox13121471","volume":"13","author":"JS Wang","year":"2024","unstructured":"Wang JS, Tsai PH, Tseng KF, Lin CL, Chen FY, Chang CT, Shen MY (2024) Long-term pentoxifylline therapy is associated with a reduced risk of atherosclerotic cardiovascular disease by inhibiting oxidative stress and cell apoptosis in diabetic kidney disease patients. Antioxidants 13:1471","journal-title":"Antioxidants"},{"key":"1949_CR85","first-page":"1","volume":"161","author":"MJ Weinstein","year":"1963","unstructured":"Weinstein MJ, Luedemann GM, Oden EM, Wagman GH (1963) Gentamicin, a new broad-spectrum antibiotic complex. Antimicrob Agents Chemother 161:1\u20137","journal-title":"Antimicrob Agents Chemother"},{"key":"1949_CR86","doi-asserted-by":"publisher","first-page":"109741","DOI":"10.1016\/j.biopha.2019.109741","volume":"123","author":"CH Weng","year":"2020","unstructured":"Weng CH, Li YJ, Wu HH, Liu SH, Hsu HH, Chen YC, Yang CW, Chu PH, Tian YC (2020) Interleukin-17A induces renal fibrosis through the ERK and Smad signaling pathways. Biomed Pharmacother 123:109741","journal-title":"Biomed Pharmacother"},{"key":"1949_CR87","doi-asserted-by":"publisher","first-page":"7094","DOI":"10.1128\/AAC.01032-15","volume":"59","author":"BP White","year":"2015","unstructured":"White BP, Lomaestro B, Pai MP (2015) Optimizing the initial Amikacin dosage in adults. Antimicrob Agents Chemother 59:7094\u20137096","journal-title":"Antimicrob Agents Chemother"},{"key":"1949_CR88","unstructured":"Yao J, Moellering R (2007) Antibacterial agents. In: Murray PR et al (eds) Manual of clinical microbiology, vol 1, 9th edn. ASM, pp 1077\u20131113"},{"key":"1949_CR89","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.1977.03280100027017","volume":"238","author":"VL Yu","year":"1977","unstructured":"Yu VL, Rhame FS, Pesanti EL, Axline SG (1977) Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms. JAMA 238:943\u2013947","journal-title":"JAMA"},{"key":"1949_CR90","first-page":"93","volume":"30","author":"SM Yuan","year":"2015","unstructured":"Yuan SM (2015) Mycobacterial endocarditis: a comprehensive review. Rev Bras Cir Cardiovasc 30:93\u2013103","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"1949_CR92","first-page":"103","volume":"9","author":"M Zhang","year":"2004","unstructured":"Zhang M, Xu YJ, Mengi SA, Arneja AS, Dhalla NS (2004) Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases. Exp Clin Cardiol 9:103\u2013111","journal-title":"Exp Clin Cardiol"},{"key":"1949_CR93","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10815-005-7202-6","volume":"22","author":"X Zhang","year":"2005","unstructured":"Zhang X, Sharma RK, Agarwal A, Falcone T (2005) Effect of pentoxifylline in reducing oxidative stress-induced embryotoxicity. J Assist Reprod Genet 22:415\u2013417","journal-title":"J Assist Reprod Genet"},{"key":"1949_CR91","doi-asserted-by":"publisher","first-page":"104607","DOI":"10.1016\/j.ebiom.2023.104607","volume":"92","author":"F Zhang","year":"2023","unstructured":"Zhang F, Yin J, Liu L, Liu S, Zhang G, Kong Y, Wang Y, Wang N, Chen X, Wang F (2023) IL-17\u00a0C neutralization protects the kidney against acute injury and chronic injury. EBioMedicine 92:104607","journal-title":"EBioMedicine"},{"key":"1949_CR94","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/1547691X.2012.724730","volume":"10","author":"X Zhu","year":"2013","unstructured":"Zhu X, Uetrecht J (2013) A novel T(H)17-type cell is rapidly increased in the liver in response to acetaminophen-induced liver injury: T(H)17 cells and the innate immune response. J Immunotoxicol 10:287\u2013291","journal-title":"J Immunotoxicol"}],"container-title":["AMB Express"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-025-01949-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13568-025-01949-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-025-01949-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T13:03:38Z","timestamp":1761138218000},"score":1,"resource":{"primary":{"URL":"https:\/\/amb-express.springeropen.com\/articles\/10.1186\/s13568-025-01949-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1949"],"URL":"https:\/\/doi.org\/10.1186\/s13568-025-01949-8","relation":{},"ISSN":["2191-0855"],"issn-type":[{"value":"2191-0855","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were carried out in accordance with the international guidelines for the care and use of laboratory animals, and the study was conducted in accordance with the guide for the care and use of laboratory animals, Eighth edition (2011). All experiment procedures were approved by the Institutional Animal Care and Use Committee (CU-IACUC), Cairo University, Egypt (CUIF6723).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}